Select Page

Home / Share Price History /

Syngene International Share Price History & Return (2015 To 2026)

Syngene International Share Price History & Return (2015 To 2026)
Show Table of Contents

Syngene International Share Highlights

As of Mon 15 Jun 2026, Syngene International Share price is ₹453.5 which is ₹275.10 below 52-week high of ₹728.6 and ₹73.50 above 52-week low of ₹380

52-Week High Low

  • Syngene International 52-Week High is ₹728.6 occurred on Wed 30 Jul 2025
  • Syngene International 52-Week Low is ₹380 occurred on Mon 06 Apr 2026

All Time High

  • The all-time high or the highest price that Syngene International shares have ever touched was ₹960.6 and this occurred on Dec 2024.
  • The highest closing price at which Syngene International shares have ever closed was ₹940.8 recorded on Nov 2024.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our Telegram channel

Your phone number will be HIDDEN to other users.

Syngene International Recent Performance

Over the past 15 trading days, the value of Syngene International's stock has decreased by ₹8.90 (-1.92%).

From 25 May 2026 to 15 Jun 2026, it reached a high of ₹472.75 and a low of ₹432.15.

Syngene International Share Price Chart From 2015 to 2026

Syngene International Share Price History Table From 2015 to 2026

Year Syngene International YOY Chg% ↑High - ↓Low
2026 ₹458.55 -29.6% ↑ ₹678.95
↓ ₹380
2025 ₹651 -24.2% ↑ ₹895.75
↓ ₹599.54
2024 ₹858.45 22.4% ↑ ₹960.6
↓ ₹607.65
2023 ₹701.45 19.8% ↑ ₹860.25
↓ ₹545
2022 ₹585.54 -5.5% ↑ ₹683
↓ ₹510.05
2021 ₹619.9 -3.1% ↑ ₹700
↓ ₹490.5
2020 ₹639.6 99.8% ↑ ₹644.54
↓ ₹212.55
2019 ₹320.14 14.3% ↑ ₹369
↓ ₹267.5
2018 ₹280.1 3.5% ↑ ₹350
↓ ₹250.05
2017 ₹270.67 -3.6% ↑ ₹308.77
↓ ₹215.05
2016 ₹280.92 34.9% ↑ ₹331.6
↓ ₹174.5
2015 ₹208.27 - ↑ ₹209.85
↓ ₹147.5

Analyzing the Impact of Investing in Syngene International

Syngene International share price in 2015 was ₹208.27. If you had invested ₹10,000 in Syngene International shares in 2015, in 11 years, your investment would have grown to ₹22,017.09 by 2026. This represents a positive return of 120.2% with a CAGR of 7.4%.

Syngene International Share Returns In Last 5 Years

  • Its highest stock price in the last 5 years was: ₹960.60 and lowest was: ₹380.00
  • Syngene International Share price in 2022 was ₹585.55
  • By 2026, its share price dropped to ₹458.55
  • It gave a negative return of -21.7% with a CAGR of -4.8% over the last 5 years
  • If you had invested ₹10,000 in Syngene International in 2022 then in 5 years, your investment would have declined to ₹7,831.09 by 2026

Syngene International Share Returns In Last 10 Years

  • Its highest stock price in the last 10 years was: ₹960.60 and lowest was: ₹212.55
  • Syngene International Share price in 2017 was ₹270.67
  • By 2026, its share price rose to ₹458.55
  • It gave a positive return of 69.4% with a CAGR of 5.4% over the last 10 years
  • If you had invested ₹10,000 in Syngene International in 2017 then in 10 years, your investment would have grown to ₹16,941.29 by 2026

Syngene International Returns vs Bank FD Returns

Investment Type Initial Amount Final Value Total Returns
Syngene International Shares ₹10,000 ₹22,017.09 120.2%
Bank FD (Simple Interest) ₹10,000 ₹16,600 66.0%
Bank FD (Compound Interest) ₹10,000 ₹18,982.98 89.8%

Short Info About Syngene International

Syngene International Limited: A Leading Contract Research and Manufacturing Company Established in 1993, Syngene International Limited is a premier provider of drug discovery and development services. Product Range: Discovery Chemistry, Discovery Biology, Chemical Development Services: Lead Generation, Preclinical Development, Clinical... Read More

Syngene International Limited: A Leading Contract Research and Manufacturing Company

Established in 1993, Syngene International Limited is a premier provider of drug discovery and development services.

  • Product Range: Discovery Chemistry, Discovery Biology, Chemical Development
  • Services: Lead Generation, Preclinical Development, Clinical Trial Management
  • Market Presence: India, Japan, Europe, the United States, and internationally
  • Reputation: Partnerships with industry giants like Bristol-Myers Squibb, Baxter Inc., and Amgen Inc.
  • Commitment: Providing innovative solutions to clients across various sectors

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. Connect on linkedin